Alcohol Use Disorder: Signs, Causes, Effects, and Evidence-Based Treatment Options

Alcohol use disorder (AUD) is a chronic, relapsing brain disorder characterized by compulsive alcohol consumption, loss of control over drinking, and continued use despite mounting physical, psychological, and social harm.

It is the most prevalent substance use disorder in the United States and one of the leading drivers of preventable death.

AUD exists on a spectrum. Mild AUD looks like a pattern of repeated heavy drinking that disrupts sleep and relationships. Severe AUD can involve daily physiological dependence, medical complications, and withdrawal seizures.

Understanding where someone falls on that spectrum is the first step toward matching them to the right level of care.

Key Takeaways

• According to the National Institute on Alcohol Abuse and Alcoholism, approximately 28.9 million Americans aged 12 and older met the DSM-5 diagnostic criteria for alcohol use disorder in 2023.
• The DSM-5 diagnoses AUD through 11 criteria, not a blood alcohol level or number of drinks consumed. Two or more criteria in 12 months constitutes a diagnosis.
• Alcohol withdrawal can produce seizures, delirium tremens, and cardiovascular instability — making medically supervised detox essential for anyone drinking heavily daily.
• Naltrexone, acamprosate, and disulfiram are the three FDA-approved pharmacological treatments for alcohol use disorder.
• Full alcohol clearance from blood takes approximately 0.015% BAC per hour, meaning a person with a 0.15% BAC requires roughly 10 hours to reach zero.

What Is Alcohol Use Disorder?

Alcohol use disorder is the DSM-5 diagnostic term for what was previously classified under separate categories of alcohol abuse and alcohol dependence. The consolidation reflects clinical evidence that alcohol-related problems exist on a continuum of severity rather than as two distinct conditions.

The National Institute on Alcohol Abuse and Alcoholism defines AUD as a medical condition in which a person drinks alcohol compulsively, cannot consistently control their drinking, and continues to drink despite negative consequences to their health, relationships, and functioning.

Alcohol Use Disorder vs. Alcohol Dependence: The DSM-5 Distinction

This distinction matters clinically because it changed how severity is assessed and how treatment is matched to the patient.

Under DSM-IV (used before 2013), alcohol dependence was diagnosed by physiological markers: tolerance, withdrawal, and impaired control. Alcohol abuse was a separate, lower-severity diagnosis focused on behavioral consequences. A person could be diagnosed with one but not both.

The DSM-5 eliminated this distinction and merged both into a single diagnosis, alcohol use disorder, rated as mild, moderate, or severe based on the number of criteria met. Physical dependence (tolerance and withdrawal) are two of the 11 criteria, not the defining feature of the diagnosis. This change is clinically important because it means a person experiencing severe social and occupational harm from alcohol, without physical dependence, still qualifies for a formal AUD diagnosis and evidence-based treatment.

The 11 DSM-5 criteria for alcohol use disorder include:

• Loss of control: drinking more or for longer than intended
• Persistent desire to cut down: repeated unsuccessful attempts to reduce drinking
• Excessive time spent: hours each day obtaining, drinking, or recovering from alcohol
• Craving: intense urges that intrude on daily thought
• Role failure: neglecting work, parenting, or school responsibilities
• Social problems: continued drinking despite interpersonal conflict it causes
• Activity reduction: giving up hobbies or social activities because of drinking
• Hazardous use: drinking in physically dangerous situations
• Physical harm awareness: continuing despite known medical consequences
• Tolerance: needing more alcohol to achieve the same effect
• Withdrawal: experiencing characteristic withdrawal symptoms when alcohol is reduced

Causes and Risk Factors

No single factor causes alcohol use disorder. It develops through an interaction of genetic vulnerability, neurobiological changes driven by repeated alcohol exposure, and environmental triggers that sustain use.

Neurobiological Mechanism

Alcohol produces its intoxicating and reinforcing effects primarily through two neurochemical pathways. It potentiates GABA-A receptor activity, producing the sedation, anxiolysis, and motor impairment characteristic of intoxication. Simultaneously, alcohol suppresses glutamate N-methyl-D-aspartate (NMDA) receptor activity, reducing excitatory neurotransmission.

With repeated heavy drinking, the brain compensates by downregulating GABA-A receptor density and upregulating glutamate excitatory activity. This neuroadaptation is the physiological basis of tolerance and withdrawal. When alcohol is removed, unmasked glutamate hyperactivity produces the hyperarousal state — tremors, anxiety, seizures, and autonomic instability — that defines alcohol withdrawal syndrome.

Alcohol also stimulates dopamine release in the nucleus accumbens, the brain’s primary reward hub. This dopamine surge reinforces the behavior of drinking through the same mesolimbic pathway that drives other substance use disorders.

Risk Factors for Developing AUD

• Family history and genetics: First-degree relatives of individuals with AUD carry roughly twice the population risk, according to NIAAA research. Multiple genes influencing alcohol metabolism and neurological reward sensitivity contribute.
• Early initiation: According to SAMHSA, people who begin drinking before age 15 are four times more likely to develop AUD than those who start at 21 or older.
• Co-occurring mental health conditions: Anxiety disorders, major depressive disorder, post-traumatic stress disorder, and bipolar disorder all increase AUD vulnerability significantly.
• Adverse childhood experiences (ACEs): Abuse, neglect, and household dysfunction during childhood are strong predictors of adult substance use disorders.
• Social environment: Peer drinking culture, community alcohol availability, and occupational stress all contribute to initiation and escalation.

Signs and Symptoms of Alcohol Use Disorder

AUD produces recognizable behavioral, physical, and psychological changes that develop progressively with increasing severity of drinking.

Behavioral Signs

• Escalating quantity and frequency: Drinking more than planned, more often than intended, and continuing longer into the night or week.
• Hiding or minimizing use: Concealing alcohol, drinking alone, or downplaying how much has been consumed to family or coworkers.
• Drinking to cope: Using alcohol as the primary strategy for managing stress, anxiety, loneliness, or interpersonal conflict.
• Continued drinking after negative consequences: Legal charges, relationship breakdown, job loss, or medical warnings do not interrupt the pattern.

Physical Signs

• Tolerance markers: Consuming quantities that would visibly impair others with no apparent effect.
• Morning drinking or drinking to prevent shaking: Both indicate physical dependence.
• Recurrent blackouts: Alcohol-induced anterograde amnesia from high blood alcohol concentration.
• Physical decline: Unexplained weight loss, jaundice, hand tremors, facial redness, and spider angiomata reflecting hepatic stress.

Withdrawal Symptoms

In physically dependent individuals, reducing or stopping alcohol produces:

• Early withdrawal (6 to 24 hours): Anxiety, tremors, sweating, nausea, elevated heart rate and blood pressure, insomnia.
• Peak withdrawal (24 to 72 hours): Worsening tremors, severe anxiety, and risk of generalized tonic-clonic seizures.
• Delirium tremens (72 to 96 hours): Occurs in approximately 5% of untreated severe withdrawal; marked by confusion, hallucinations, autonomic instability, and hyperthermia. Without medical intervention, delirium tremens carries a mortality rate of 5 to 15%.

Anyone who drinks heavily daily and is considering stopping should seek medically supervised detox and rehabilitation rather than attempting to stop abruptly at home.

How Long Does Alcohol Stay in Your System?

This is one of the most frequently searched questions by people beginning to reckon with their drinking, and it directly intersects with understanding physical dependence.

The liver metabolizes approximately one standard drink per hour at a rate of 0.015% blood alcohol concentration (BAC) per hour. This rate is relatively fixed and is not meaningfully accelerated by water intake, food, exercise, or sleep.

Detection Windows by Test Type

Test Type	Detection Window
Breath test	Up to 24 hours
Blood test	Up to 24 hours
Urine (ethanol)	12 to 24 hours
Urine (EtG biomarker)	Up to 80 hours
Hair follicle	Up to 90 days

What This Means Clinically

A person with a BAC of 0.15%, nearly double the legal driving limit, requires approximately 10 hours of abstinence for full alcohol clearance from blood. For a person drinking a bottle of wine or more daily, withdrawal symptoms typically begin within 6 to 24 hours of the last drink, precisely when BAC is falling but not yet zero.

The EtG (ethyl glucuronide) urine test detects alcohol metabolites for up to 80 hours after drinking, making it a clinically useful tool for monitoring abstinence in intensive outpatient settings, including Right Choice Recovery’s partial care program.

Health Effects of Alcohol Use Disorder

Short-Term Effects

Acute alcohol intoxication suppresses the central nervous system in a dose-dependent pattern. At low BAC, disinhibition and sedation occur. At higher BAC, GABA-A potentiation produces significant motor impairment, slurred speech, coordination failure, and impaired judgment. At very high BAC (above 0.30%), respiratory depression and death from alcohol poisoning are possible.

Long-Term Effects

Chronic heavy drinking produces progressive organ damage across multiple systems:

• Hepatic: Alcoholic fatty liver disease progressing to alcoholic hepatitis, and in sustained heavy drinkers, alcoholic cirrhosis. The National Institute on Alcohol Abuse and Alcoholism reports that heavy drinking accounts for a large proportion of liver transplant referrals nationally.
• Neurological: Wernicke-Korsakoff syndrome, a thiamine deficiency-driven encephalopathy producing severe anterograde and retrograde amnesia; peripheral neuropathy; and cerebellar degeneration producing gait ataxia.
• Cardiovascular: Cardiomyopathy, atrial fibrillation, and hypertension with sustained heavy drinking, despite a paradoxical protective effect at very low intake levels in some observational studies.
• Gastrointestinal: Pancreatitis, both acute and chronic, and elevated risk of esophageal, gastric, and colorectal cancers.
• Immunological: Suppressed immune function increasing susceptibility to pneumonia, tuberculosis, and other infections.
• Psychiatric: Alcohol-induced depressive disorder, alcohol-induced anxiety disorder, and significantly elevated suicide risk.

Treatment for Alcohol Use Disorder

Effective AUD treatment combines behavioral therapy, medication management, peer support, and a structured step-down care continuum. The evidence overwhelmingly supports integrated treatment over any single modality.

Evidence-Based Behavioral Therapies

• Cognitive behavioral therapy (CBT): Identifies high-risk drinking cues and builds specific coping responses. Reduces relapse risk by restructuring the thought patterns that precede drinking episodes.
• Motivational interviewing: Resolves ambivalence and builds intrinsic motivation to change. Most effective in early treatment engagement and for patients who are ambivalent about the severity of their AUD.
• 12-step facilitation (TSF): Structured preparation for engagement in 12-step programs such as Alcoholics Anonymous. NIDA endorses TSF as an evidence-based adjunct to clinical care with demonstrated outcomes.
• Contingency management: Tangible incentives for negative alcohol screens and treatment attendance.

FDA-Approved Medications for AUD

The three FDA-approved pharmacological treatments are:

• Naltrexone (oral Revia or monthly injectable Vivitrol): Blocks mu-opioid receptor-mediated dopamine release, reducing alcohol’s rewarding effects and reducing heavy drinking days.
• Acamprosate (Campral): Modulates glutamate and GABA to reduce protracted withdrawal craving and support abstinence maintenance after detox.
• Disulfiram (Antabuse): Creates an aversive acetaldehyde reaction if the patient consumes alcohol, requiring full abstinence to be used safely.

For information on nalmefene, a European-approved opioid antagonist for AUD with a distinct as-needed dosing protocol, see our article on nalmefene for alcohol use disorder.

Levels of Care

• Medical detoxification is the required first step for patients with physical dependence. Right Choice Recovery coordinates with medical detox partners for patients who need supervised alcohol withdrawal management before outpatient care begins.
• The partial care program provides intensive daytime structure for patients transitioning from detox or those in early high-risk recovery.
• The intensive outpatient program offers morning and evening scheduling, making structured AUD treatment compatible with work and family obligations.

Same-day clinical assessments are available. Insurance verification is completed at no cost before services begin.

References

1. National Institute on Alcohol Abuse and Alcoholism. (2024). Alcohol use disorder: A comparison between DSM-IV and DSM-5. https://www.niaaa.nih.gov/
2. Substance Abuse and Mental Health Services Administration. (2024). Key substance use and mental health indicators in the United States: 2023 NSDUH. https://www.samhsa.gov/
3. National Institute on Alcohol Abuse and Alcoholism. (2024). Alcohol use disorder treatment options. https://www.niaaa.nih.gov/
4. Centers for Disease Control and Prevention. (2024). Alcohol use and health. https://www.cdc.gov/
5. American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders (5th ed.).
6. National Institute on Drug Abuse. (2023). Principles of drug addiction treatment (3rd ed.). https://nida.nih.gov/